Interest in self-administration of subcutaneous depot medroxyprogesterone acetate in the United States-Reference-Cited by-同舟云学术

Interest in self-administration of subcutaneous depot medroxyprogesterone acetate in the United States

Published:2016-10 Issue:4 Volume:94 Page:303-313
ISSN:0010-7824
Container-title:Contraception
language:en
Short-container-title:Contraception

Author:

Upadhyay Ushma D.,Zlidar Vera M.,Foster Diana Greene

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Reproductive Medicine

Reference40 articles.

1. Building on safety, feasibility, and acceptability: the impact and cost of community health worker provision of injectable contraception;Chin-Quee;Glob Health Sci Pract,2013

2. Subcutaneous dmpa: a better lower dose approach;Shelton;Contraception,2014

3. Current contraceptive status among women aged 15–44: United States, 2011-2013;Daniels;NCHS Data Brief,2014

4. Key statistics from the national survey of family growth - injectable contraceptives;US Centers for Disease Control National Center for Health Statistics,2015

5. Contraceptive failure in the United States;Trussell;Contraception,2011

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patient experiences switching from in‐clinic to self‐administration of injectable contraception in two Western US states;Perspectives on Sexual and Reproductive Health;2024-07-04

2. Provision of DMPA-SC for self-administration in different practice settings during the COVID-19 pandemic: Data from providers across the United States;Contraception;2024-03

3. Patient’s experience and satisfaction with self-administered subcutaneous depot medroxyprogesterone acetate use during the first year of COVID-19;Contraception;2023-07

4. Hormonothérapie injectable et réduction des risques : pratiques, difficultés, santé des personnes trans en France;Santé Publique;2023-05-07

5. Women’s preferences and acceptance for different drug delivery routes and products;Advanced Drug Delivery Reviews;2022-03